您当前的位置：
首页 >
文章列表页 >
Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology
更新时间：2025-04-30

    • Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology

    • “The research team of the Department of Endocrinology of Peking University Third Hospital used 5hmC Seal sequencing technology and network pharmacology to chemically cut Buyang Huanwu Decoction, improve its therapeutic effect on diabetes nephropathy, and provide new ideas for mining Chinese medicines.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 11, Pages: 208-217(2025)

    • DOI：10.13422/j.cnki.syfjx.20250514    

      CLC： R692;R285;R289

    • Received：19 March 2025，

      Accepted：2025-04-09，

      Published Online：10 April 2025，

      Published：05 June 2025

    移动端阅览

  • ZHEN Baixin,CHEN Haoyu,MAIMAITIYASEN Duolikun,et al.Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):208-217. DOI： 10.13422/j.cnki.syfjx.20250514.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway
Danggui Buxuetang Inhibits Mitochondrial Fission and Apoptosis of Podocytes in Rat of Diabetic Kidney Disease via AKAP1/Drp1 Signaling Pathway
Regulation of Mitochondrial Quality Control in Treatment of Diabetic Kidney Disease by Traditional Chinese Medicine： A Review
Role of Wnt/β-catenin Signaling Pathway in Seborrheic Alopecia and Its Intervention with Traditional Chinese Medicine： A Review
Effect of Danggui Buxuetang on Podocyte Pyroptosis in Diabetic Kidney Disease Rats： An Exploration Based on TXNIP/NLRP3/GSDMD Signaling Pathway

Related Author

GU Yue
SHEN Yuhang
DING Xin
WANG Yifan
ZHANG Yuanyuan
ZHENG Linlin
GUO Dengzhou
ZHENG Linlin

Related Institution

The First Affiliated Hospital of Hebei University of Chinese Medicine，Hebei Provincial Hospital of Traditional Chinese Medicine
Lucheng Community Health Center of Tongzhou District
Hebei University of Chinese Medicine
The First Affiliated Hospital of Liaoning University of TCM
Liaoning University of Traditional Chinese Medicine（TCM）
0